Literature DB >> 19535633

STAT6 activation confers upon T helper cells resistance to suppression by regulatory T cells.

Brendan B L Pillemer1, Zengbiao Qi, Barbro Melgert, Timothy B Oriss, Prabir Ray, Anuradha Ray.   

Abstract

Recent studies have highlighted characteristics of T regulatory cells (Tregs) that underlie their suppressive function. However, mechanisms that override their suppressive function in the context of an adaptive immune response are not well understood. In the lungs of mice undergoing allergic inflammation, appreciable numbers of Tregs were identified that possessed suppressive function when assayed ex vivo. We investigated whether the Th2-promoting cytokine IL-4 played a permissive role that superseded Treg function, thereby allowing the development of allergic inflammation. IL-4 signaling via the IL-4Ralpha-STAT6 axis was required to maintain Foxp3 expression in Tregs and promote their proliferation. However, the results of both in vivo experiments involving adoptive transfer of Tregs into Ag-sensitized vs naive animals and in vitro suppression assays performed with or without exogenous IL-4 showed the ability of IL-4 to compromise Treg-mediated suppression. Use of retrovirally expressed, constitutively active STAT6 revealed that the underlying mechanism was not IL-4-mediated dysfunction of Tregs but involved the resistance of Th cells to Treg-mediated suppression that would permit the development of an adaptive immune response. Our data suggest that infectious tolerance, mediated by membrane-bound TGF-beta expressed by Tregs, is compromised by the competing effects of IL4-induced signaling in naive CD4(+) Th cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19535633      PMCID: PMC2754746          DOI: 10.4049/jimmunol.0803733

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  50 in total

1.  Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells.

Authors:  Steven J Bensinger; Patrick T Walsh; Jidong Zhang; Martin Carroll; Ramon Parsons; Jeffrey C Rathmell; Craig B Thompson; Matthew A Burchill; Michael A Farrar; Laurence A Turka
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

2.  The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells.

Authors:  W Zheng; R A Flavell
Journal:  Cell       Date:  1997-05-16       Impact factor: 41.582

3.  IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway.

Authors:  J Zamorano; H Y Wang; L M Wang; J H Pierce; A D Keegan
Journal:  J Immunol       Date:  1996-12-01       Impact factor: 5.422

4.  Stat6 is required for mediating responses to IL-4 and for development of Th2 cells.

Authors:  M H Kaplan; U Schindler; S T Smiley; M J Grusby
Journal:  Immunity       Date:  1996-03       Impact factor: 31.745

5.  Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene.

Authors:  D H Zhang; L Cohn; P Ray; K Bottomly; A Ray
Journal:  J Biol Chem       Date:  1997-08-22       Impact factor: 5.157

6.  Tolerance induced by inhaled antigen involves CD4(+) T cells expressing membrane-bound TGF-beta and FOXP3.

Authors:  Marina Ostroukhova; Carole Seguin-Devaux; Timothy B Oriss; Barbara Dixon-McCarthy; Liyan Yang; Bill T Ameredes; Timothy E Corcoran; Anuradha Ray
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

7.  Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene.

Authors:  K Shimoda; J van Deursen; M Y Sangster; S R Sarawar; R T Carson; R A Tripp; C Chu; F W Quelle; T Nosaka; D A Vignali; P C Doherty; G Grosveld; W E Paul; J N Ihle
Journal:  Nature       Date:  1996-04-18       Impact factor: 49.962

8.  Essential role of Stat6 in IL-4 signalling.

Authors:  K Takeda; T Tanaka; W Shi; M Matsumoto; M Minami; S Kashiwamura; K Nakanishi; N Yoshida; T Kishimoto; S Akira
Journal:  Nature       Date:  1996-04-18       Impact factor: 49.962

9.  Role of IRS-2 in insulin and cytokine signalling.

Authors:  X J Sun; L M Wang; Y Zhang; L Yenush; M G Myers; E Glasheen; W S Lane; J H Pierce; M F White
Journal:  Nature       Date:  1995-09-14       Impact factor: 49.962

10.  Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4.

Authors:  A Vella; T K Teague; J Ihle; J Kappler; P Marrack
Journal:  J Exp Med       Date:  1997-07-21       Impact factor: 14.307

View more
  39 in total

1.  Cytokine-conditioned dendritic cells induce humoral tolerance to protein therapy in mice.

Authors:  Gautam Sule; Masataka Suzuki; Kilian Guse; Racel Cela; John R Rodgers; Brendan Lee
Journal:  Hum Gene Ther       Date:  2012-05-11       Impact factor: 5.695

Review 2.  Regulation of the T helper cell type 2 (Th2)/T regulatory cell (Treg) balance by IL-4 and STAT6.

Authors:  Svetlana Chapoval; Preeta Dasgupta; Nicolas J Dorsey; Achsah D Keegan
Journal:  J Leukoc Biol       Date:  2010-03-24       Impact factor: 4.962

Review 3.  T-cell biology in immunotherapy.

Authors:  John W Steinke; Monica G Lawrence
Journal:  Ann Allergy Asthma Immunol       Date:  2014-01-14       Impact factor: 6.347

4.  Bcl6 controls the Th2 inflammatory activity of regulatory T cells by repressing Gata3 function.

Authors:  Deepali V Sawant; Sarita Sehra; Evelyn T Nguyen; Rohit Jadhav; Kate Englert; Ryo Shinnakasu; Giao Hangoc; Hal E Broxmeyer; Toshinori Nakayama; Narayanan B Perumal; Mark H Kaplan; Alexander L Dent
Journal:  J Immunol       Date:  2012-10-10       Impact factor: 5.422

5.  A Stat6/Pten Axis Links Regulatory T Cells with Adipose Tissue Function.

Authors:  Stefanie Kälin; Maike Becker; Verena B Ott; Isabelle Serr; Fabian Hosp; Mohammad M H Mollah; Susanne Keipert; Daniel Lamp; Francoise Rohner-Jeanrenaud; Victoria K Flynn; Martin G Scherm; Lucas F R Nascimento; Katharina Gerlach; Vanessa Popp; Sarah Dietzen; Tobias Bopp; Purna Krishnamurthy; Mark H Kaplan; Manuel Serrano; Stephen C Woods; Philipp Tripal; Ralf Palmisano; Martin Jastroch; Matthias Blüher; Christian Wolfrum; Benno Weigmann; Anette-Gabriele Ziegler; Matthias Mann; Matthias H Tschöp; Carolin Daniel
Journal:  Cell Metab       Date:  2017-09-05       Impact factor: 27.287

Review 6.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

7.  Allergic conjunctivitis renders CD4(+) T cells resistant to t regulatory cells and exacerbates corneal allograft rejection.

Authors:  N J Reyes; P W Chen; J Y Niederkorn
Journal:  Am J Transplant       Date:  2013-03-13       Impact factor: 8.086

Review 8.  Characterization of CD4+ T cell subsets in allergy.

Authors:  Erik Wambre; Eddie A James; William W Kwok
Journal:  Curr Opin Immunol       Date:  2012-08-10       Impact factor: 7.486

9.  Macrophages: regulators of sex differences in asthma?

Authors:  Barbro N Melgert; Timothy B Oriss; Zengbiao Qi; Barbara Dixon-McCarthy; Marie Geerlings; Machteld N Hylkema; Anuradha Ray
Journal:  Am J Respir Cell Mol Biol       Date:  2009-07-02       Impact factor: 6.914

10.  IL-28 supplants requirement for T(reg) cells in protein sigma1-mediated protection against murine experimental autoimmune encephalomyelitis (EAE).

Authors:  Agnieszka Rynda; Massimo Maddaloni; Javier Ochoa-Repáraz; Gayle Callis; David W Pascual
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.